Catalyst Pharmaceuticals, Inc. (DELISTED) (CPRX:DL)
31.49
0.00 (0.00%)
USD |
NASDAQ |
Jul 24, 16:00
Catalyst Pharmaceuticals Net Income (Quarterly) : 63.73M for March 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 63.73M |
| December 31, 2025 | 52.70M |
| September 30, 2025 | 52.78M |
| June 30, 2025 | 52.11M |
| March 31, 2025 | 56.74M |
| December 31, 2024 | 55.94M |
| September 30, 2024 | 43.88M |
| June 30, 2024 | 40.79M |
| March 31, 2024 | 23.28M |
| December 31, 2023 | 34.84M |
| September 30, 2023 | -30.76M |
| June 30, 2023 | 37.76M |
| March 31, 2023 | 29.57M |
| December 31, 2022 | 25.47M |
| September 30, 2022 | 22.75M |
| June 30, 2022 | 21.62M |
| March 31, 2022 | 13.24M |
| December 31, 2021 | 9.309M |
| September 30, 2021 | 10.33M |
| June 30, 2021 | 12.18M |
| March 31, 2021 | 7.663M |
| December 31, 2020 | 11.44M |
| September 30, 2020 | 43.34M |
| June 30, 2020 | 9.78M |
| March 31, 2020 | 10.43M |
| Date | Value |
|---|---|
| December 31, 2019 | 7.930M |
| September 30, 2019 | 13.63M |
| June 30, 2019 | 10.96M |
| March 31, 2019 | -0.6445M |
| December 31, 2018 | -14.50M |
| September 30, 2018 | -7.839M |
| June 30, 2018 | -5.965M |
| March 31, 2018 | -5.700M |
| December 31, 2017 | -5.388M |
| September 30, 2017 | -4.178M |
| June 30, 2017 | -3.880M |
| March 31, 2017 | -4.967M |
| December 31, 2016 | -4.163M |
| September 30, 2016 | -3.954M |
| June 30, 2016 | -4.569M |
| March 31, 2016 | -5.386M |
| December 31, 2015 | -5.815M |
| September 30, 2015 | -4.449M |
| June 30, 2015 | -4.558M |
| March 31, 2015 | -5.410M |
| December 31, 2014 | -3.49M |
| September 30, 2014 | -5.010M |
| June 30, 2014 | -3.198M |
| March 31, 2014 | -3.811M |
| December 31, 2013 | -1.355M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -6.012M |
| Indivior Pharmaceuticals, Inc. | 122.00M |
| Exelixis, Inc. | 212.05M |
| United Therapeutics Corp. | 333.00M |
| Krystal Biotech, Inc. | 54.77M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 149.39M |
| Total Expenses (Quarterly) | 85.66M |
| EPS Diluted (Quarterly) | 0.5022 |
| Enterprise Value | 3.094B |
| Gross Profit Margin (Quarterly) | 83.82% |
| Profit Margin (Quarterly) | 42.66% |
| Earnings Yield | 5.52% |
| Operating Earnings Yield | 6.68% |
| Normalized Earnings Yield | 5.471 |